Eating disorders: Anorexia and bulimia nervosa

Handbook of Clinical Neurology

Volumn 106, Issue , 2012, Pages 447-462

  Herpertz dahlmann, B ^a   Holtkamp, K ^b   Konrad, K ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b DRK Clinic of Child and Adolescent Psychiatry   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861128689     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52002-9.00026-7     Document Type: Chapter

References (112)

1. Adrian T.E., Long R.G., Fuessl H.S., et al. Plasma peptide YY (PYY) in dumping syndrome. Dig Dis Sci 1985, 30:1145-1148.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th edn.
3. Andreason P.J., Altemus M., Zametkin A.J., et al. Regional cerebral glucose metabolism in bulimia nervosa. Am J Psychiatry 1992, 149:1506-1513.
4. Attia E. Anorexia nervosa: current status and future directions. Annu Rev Med 2010, 61:7.1-7.11.
5. Baranowska B., Radzikowska M., Wasilewska-Dziubinska E., et al. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes Obes Metab 2000, 2:99-103.
6. Batterham R.L., Bloom S.R. The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci 2003, 994:162-168.
7. Bayless J.D., Kanz J.E., Moser D.J., et al. Neuropsychological characteristics of patients in a hospital-based eating disorder program. Ann Clin Psychiatry 2002, 14:203-207.
8. Bergen A.W., Yeager M., Welch R.A., et al. Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology 2005, 30:1703-1710.
9. Bissada H., Tasca G.A., Barber A.M., et al. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2008, 165:1281-1288.
10. Blouin A., Blouin J., Aubin P., et al. Seasonal patterns of bulimia nervosa. Am J Psychiatry 1992, 149:73-81.
11. Brambilla F., Brunetta M., Peirone A., et al. T-lymphocyte cholecystokinin-8 and beta-endorphin concentrations in eating disorders: I. Anorexia nervosa. Psychiatry Res 1995, 59:43-50.
12. Brambilla F., Brunetta M., Draisci A., et al. T-lymphocyte concentrations of cholecystokinin-8 and beta-endorphin in eating disorders: II. Bulimia nervosa. Psychiatry Res 1995, 59:51-56.
13. Brewerton T.D., Steiger H. Neurotransmitter dysregulation in anorexia nervosa, bulimia nervosa, and binge eating disorder. Clinical Handbook of Eating Disorders 2004, 257-282. Marcel Dekker, New York. T.D. Brewerton (Ed.).
14. Bulik C.M., Berkman N.D., Brownley K.A., et al. Anorexia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007, 40:310-320.
15. Bulik C.M., Slof-Op't Landt M.C.T., et al. The genetics of anorexia nervosa. Annu Rev Nutr 2007, 27:263-275.
16. Calandra C., Musso F., Musso R. The role of leptin in the etiopathogenesis of anorexia nervosa and bulimia. Eat Weight Disord 2003, 8:130-137.
17. Castro-Fornieles J., Bargallo N., Lazaro L., et al. Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy. J Psychiatr Res 2007, 41:952-958.
18. Castro-Fornieles J., Bargalló N., Lázaro L., et al. A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa. J Psychiatr Res 2009, 43:331-340. 14.
19. Cnattingius S., Hultman C.M., Dahl M., et al. Very preterm birth, birth trauma, and the risk of anorexia nervosa among girls. Arch Gen Psychiatry 1999, 56:634-638.
20. Connan F., Murphy F., Connor S.E., et al. Hippocampal volume and cognitive function in anorexia nervosa. Psychiatry Res 2006, 146:117-125.
21. Culbert K.M., Breedlove S.M., Burt S.A., et al. Prenatal hormone exposure and risk for eating disorders: a comparison of opposite-sex and same-sex twins. Arch Gen Psychiatry 2008, 65:329-336.
22. Currin L., Schmidt U., Treasure J., et al. Time trends in eating disorder incidence. Br J Psychiatry 2005, 186:132-135.
23. Delvenne V., Goldman S., Simon Y., et al. Brain hypometabolism of glucose in bulimia nervosa. Int J Eat Disord 1997, 21:313-320.
24. Devlin M.J., Walsh B.T., Guss J.L., et al. Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. Am J Clin Nutr 1997, 65:114-120.
25. Exner C., Hebebrand J., Remschmidt H., et al. Leptin suppresses semi-starvation induced hyperactivity in raimplications for anorexia nervosa. Mol Psychiatry 2000, 5:476-481.
26. Fairburn C.G. Evidence-based treatment of anorexia nervosa. Int J Eat Disord 2005, 37:S26-S30.
27. Fetissov S.O., Hamze Sinno M., Coquerel Q., et al. Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders. Nutrition 2008, 24:854-859.
28. Fichter M., Quadflieg N. Twelve-year course and outcome of bulimia nervosa. Psychol Med 2004, 34:1395-1406.
29. Frank G.K., Bailer U.F., Henry S.E. Increased Dopamine D2/D3 Receptor Binding After Recovery from Anorexia Nervosa Measured by Positron Emission Tomography and [11C]Raclopride. Biol Psych 2005, 58:908-912.
30. Frank G.K., Wagner A., Achenbach S., et al. Altered brain activity in women recovered from bulimic-type eating disorders after a glucose challenge: a pilot study. Int J Eat Disord 2006, 39:76-79.
31. Frank G.K., Bailer U.F., Meltzer C.C., et al. Regional cerebral blood flow after recovery from anorexia or bulimia nervosa. Int J Eat Disord 2007, 40:488-492.
32. Gendall K.A., Kaye W.H., Altemus M., et al. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry 1999, 46:292-299.
33. Geracioti T.D., Liddle R.A. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 1988, 319:683-688.
34. Giordano G.D., Renzetti P., Parodi R.C., et al. Volume measurement with magnetic resonance imaging of hippocampus-amygdala formation in patients with anorexia nervosa. J Endocrinol Invest 2001, 24:510-514.
35. Haas V., Onur S., Paul T., et al. Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. Am J Clin Nutr 2005, 81:889-896.
36. Harty R.F., Pearson P.H., Solomon T.E., et al. Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa. Regul Pept 1991, 36:141-150.
37. Harvey J. Leptin regulation of neuronal excitability and cognitive function. Curr Opin Pharmacol 2007, 7:643-647.
38. Hebebrand J., Blum W.F., Barth N., et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry 1997, 2:330-334.
39. Hebebrand J., Muller T.D., Holtkamp K., et al. The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry 2007, 12:23-35.
40. Herpertz S., Albus C., Lichtblau K., et al. Relationship of weight and eating disorders in type 2 diabetic patiena multicenter study. Int J Eat Disord 2000, 28:68-77.
41. Herpertz-Dahlmann B. Adolescent eating disorders: definitions, symptomatology, epidemiology and comorbidity. Child Adolesc Psychiatric Clin N Am 2009, 18:31-47.
42. Herpertz-Dahlmann B., Hebebrand J. Assessment and treatment of eating disorders and obesity. Pediatric Psychopharmacology 2010, 570-586. Oxford University Press. A. Martin, C.J. Scahill L Kratochvil (Eds.).
43. Herpertz-Dahlmann B., Salbach-Andrae H. Overview of treatment modalities in adolescent anorexia nervosa. Child Adolesc Psychiatr Clin North Am 2009, 18:131-145.
44. Herpertz-Dahlmann B., Müller B., Herpertz S., et al. Prospective ten-year follow-up in adolescent anorexia nervosa - course, outcome and psychiatric comorbidity. J Child Psychol Psychiatry 2001, 42:603-612.
45. Hinney A., Friedel S., Remschmidt H., et al. Genetic risk factors in eating disorders. Am J Pharmacogenomics 2004, 4:209-223.
46. Hoek H.W. Incidence, prevalence and mortality of anorexia and other eating disorders. Curr Opin Psychiatry 2006, 19:389-394.
47. Hoek H.W., van Harten P.N., Hermans K.M., et al. The incidence of anorexia nervosa on Curacao. Am J Psychiatry 2005, 162:748-752.
48. Holtkamp K., Mika C., Grzella I., et al. Reproductive function during weight gain in anorexia nervosa. Leptin represents a metabolic gate to gonadotropin secretion. J Neural Transm 2003, 110:427-435.
49. Holtkamp K., Hebebrand J., Mika C., et al. High serum leptin levels subsequent to weight gain predict renewed weight loss in patients with anorexia nervosa. Psychoneuroendocrinology 2004, 29:791-797.
50. Holtkamp K., Herpertz-Dahlmann B., Hebebrand K., et al. Physical activity and restlessness correlate with leptin levels in patients with adolescent anorexia nervosa. Biol Psychiatry 2006, 60:311-313.
51. Husain M.M., Black K.J., Doraiswamy P.M., et al. Subcortical brain anatomy in anorexia and bulimia. Biol Psychiatry 1992, 31:735-738.
52. Jacobi C., Morris L., de Zwaan M. An overview of risk factors for anorexia nervosa, bulimia nervosa, and binge eating disorder. Clinical Handbook of Eating Disorders 2004, 117-163. Marcel Dekker, New York. D.B. Brewerton (Ed.).
53. Jimerson D.C., Mantzoros C., Wolfe B.E., et al. Decreased serum leptin in bulimia nervosa. J Clin Endocrinol Metab 2000, 85:4511-4514.
54. Kato T., Shioiri T., Murashita J., et al. Phosphorus-31 magnetic resonance spectroscopic observations in 4 cases with anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:719-724.
55. Katzman D.K., Lambe E.K., Mikulis D.J., et al. Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. J Pediatr 1996, 129:794-803.
56. Katzman D.K., Zipursky R.B., Lambe E.K., et al. A longitudinal magnetic resonance imaging study of brain changes in adolescents with anorexia nervosa. Arch Pediatr Adolesc Med 1997, 151:793-797.
57. Kaye W.H., Berrettini W., Gwirtsman H., et al. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry 1990, 47:548-556.
58. Kaye W.H., Fudge J.L., Paulus M. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 2009, 10:573-584.
59. Keel P.K., Mitchell J.E., Miller K.B., et al. Long-term outcome of bulimia nervosa. Arch Gen Psychiatry 1999, 56:63-69.
60. Keel P.K., Wolfe B.E., Liddle R.A., et al. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa. Arch Gen Psychiatry 2007, 64:1058-1066.
61. Keski-Rahkonen A., Hoek H.W., Susser E.S., et al. Epidemiology and course of anorexia nervosa in the community. Am J Psychiatry 2007, 164:1259-1265.
62. Kojima S., Nakahara T., Nagai N., et al. Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clin Endocrinol (Oxf) 2005, 62:74-78.
63. Lauer C.J., Gorzewski B., Gerlinghoff M., et al. Neuropsychological assessments before and after treatment in patients with anorexia nervosa and bulimia nervosa. J Psychiatr Res 1999, 33:129-138.
64. Lydiard R.B., Brewerton T.D., Fossey M.D., et al. CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. Am J Psychiatry 1993, 150:1099-1101.
65. Mantzoros C., Flier J.S., Lesem M.D., et al. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin Endocrinol Metab 1997, 82:1845-1851.
66. Marsh R., Steinglass J.E., Gerber A.J., et al. Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa. Arch Gen Psychiatry 2009, 66:51-63.
67. McCormick L.M., Keel P.K., Brumm M.C., et al. Implications of starvation-induced change in right dorsal anterior cingulate volume in anorexia nervosa. Int J Eat Disord 2008, 41:602-610.
68. McIntosh V.V., Jordan J., Carter F.A., et al. Three psychotherapies for anorexia nervosa: a randomized, controlled trial. Am J Psychiatry 2005, 162:741-747.
69. Miljic D., Pekic S., Djurovic M., et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 2006, 91:1491-1495.
70. Misra M., Miller K.K., Tsai P., et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006, 91:1027-1033.
71. Monteleone P., Martiadis V., Colurcio B., et al. Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa. Psychosom Med 2002, 64:874-879.
72. Monteleone P., Martiadis V., Fabrazzo M., et al. Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours. Psychol Med 2003, 33:1387-1394.
73. Monteleone P., Martiadis V., Rigamonti A.E., et al. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol Psychiatry 2005, 57:926-931.
74. Monteleone P., Fabrazzo M., Tortorella A., et al. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa. Psychoneuroendocrinology 2005, 30:243-250.
75. Monteleone P., Serritella C., Martiadis V., et al. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J Clin Endocrinol Metab 2008, 93:4418-4421.
76. Muhlau M., Gaser C., Ilg R., et al. Gray matter decrease of the anterior cingulate cortex in anorexia nervosa. Am J Psychiatry 2007, 164:1850-1857.
77. Neufang S., Specht K., Hausmann M., et al. Sex differences and the impact of steroid hormones on the developing human brain. Cereb Cortex 2009, 19:464-473.
78. Neumärker K.J., Dudeck U., Meyer U., et al. Anorexia nervosa and sudden death in childhood: clinical data and results obtained from quantitative neurohistological investigations of cortical neurons. Eur Arch Psychiatry Clin Neurosci 1997, 247:16-22.
79. Nicholls D., Viner R. Eating disorders and weight problems. BMJ 2005, 330:950-953.
80. Otto B., Cuntz U., Fruehauf E., et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001, 145:669-673.
81. Otto B., Tschop M., Fruhauf E., et al. Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology 2005, 30:577-581.
82. Otto B., Cuntz U., Otto C., et al. Peptide YY release in anorectic patients after liquid meal. Appetite 2007, 48:301-304.
83. Peters J.H., Simasko S.M., Ritter R.C. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin. Physiol Behav 2006, 89:477-485.
84. Pfluger P.T., Kampe J., Castaneda T.R., et al. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab 2007, 92:583-588.
85. Raposinho P.D., Pierroz D.D., Broqua P., et al. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Mol Cell Endocrinol 2001, 185:195-204.
86. Redgrave G.W., Bakker A., Bello N.T., et al. Differential brain activation in anorexia nervosa to Fat and Thin words during a Stroop task. Neuroreport 2008, 19:1181-1185.
87. Roberts M.E., Tchanturia K., Stahl D., et al. A systematic review and meta-analysis of set-shifting ability in eating disorders. Psychol Med 2007, 30:1-12.
88. Ruderman A.J. Dietary restraint: a theoretical and empirical review. Psychol Bull 1986, 99:105-109.
89. Sachdev P., Mondraty N., Wen W., et al. Brains of anorexia nervosa patients process self-images differently from non-self-images: an fMRI-study. Neuropsychologia 2008, 46:2161-2168.
90. Santel S., Baving L., Krauel K., et al. Hunger and satiety in anorexia nervosa. fMRI during cognitive processing of food pictures. Brain Res 2006, 1114:138-148.
91. Schienle A., Schäfer A., Hermann A., et al. Binge-eating disorder: reward sensitivity and brain activation to images of food. Biol Psychiatry 2009, 65:651-654.
92. Schmidt U. Cognitive behavioral approaches in adolescent anorexia and bulimia nervosa. Child Adolesc Psychiatr Clin N Am 2009, 18:147-158.
93. Seeger G., Braus D.F., Ruf M., et al. Body image distortion reveals amygdala activation in patients with anorexia nervosa - a functional magnetic resonance imaging study. Neurosci Lett 2002, 21:25-28.
94. Shapiro J.R., Berkman N.D., Brownley K.A., et al. Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007, 40:321-336.
95. Steinglass J.E., Walsh B.T., Stern Y. Set shifting deficit in anorexia nervosa. J Int Neuropsychol Soc 2006, 12:431-435.
96. Steinhausen H.C. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 2002, 159:1284-1293.
97. Stock S., Leichner P., Wong A.C., et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 2005, 90:2161-2168.
98. Swayze V.W., Andersen A.E., Andreasen N.C., et al. Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization. Int J Eat Disord 2003, 33:33-44.
99. Tamai H., Takemura J., Kobayashi N., et al. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism 1993, 42:581-584.
100. Tanaka M., Naruo T., Nagai N., et al. Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders. J Psychiatr Res 2003, 37:17-22.
101. Tanaka M., Nakahara T., Muranaga T., et al. Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive-behavioral treatment in patients with bulimia nervosa. Horm Behav 2006, 50:261-265.
102. Tolle V., Kadem M., Bluet-Pajot M.T., et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 2003, 88:109-116.
103. Tomasik P.J., Sztefko K., Starzyk J. Cholecystokinin, glucose dependent insulinotropic peptide and glucagon-like peptide 1 secretion in children with anorexia nervosa and simple obesity. J Pediatr Endocrinol Metab 2004, 17:1623-1631.
104. Treasure J., Claudino A.M., Zucker N. Eating disorders. Lancet 2010, 275:583-593.
105. Uher R., Treasure J. Brain lesions and eating disorders. J Neurol Neurosurg Psychiatry 2005, 76:852-857.
106. Uher R., Murphy T., Friederich H.C., et al. Functional neuroanatomy of body shape perpection in healthy and eating-disordered women. Biol Psychiatry 2005, 58:990-997.
107. Van Hoeken D., Seidell J., Hoek H.W. Epidemiology. Handbook of Eating Disorders 2003, 11-34. Wiley, Chichester. 2nd edn. J. Tresure, U. Schmidt, E. van Furth (Eds.).
108. Wagner A., Ruf M., Braus D.F., et al. Neuronal activity changes and body image distortion in anorexia nervosa. Neuroreport 2003, 14:2193-2197.
109. Wagner A., Aizenstein H., Venkatraman V.K., et al. Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 2007, 164:1842-1849.
110. Wagner A., Aizenstein H., Mazurkewicz L., et al. Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa. Neuropsychopharmacology 2008, 33:513-523.
111. Walsh B.T., Kaplan A.S., Attia E., et al. Fluoxetine after weight restoration in anorexia nervosa. J Am Med Ass 2006, 295:2605-2612.
112. Wentz-Nilsson E.W., Gillberg C., Gillberg I.C., et al. Ten-year follow-up of adolescent-onset anorexia nervosa: personality disorders. J Am Acad Child Adolesc Psychiatry 1999, 38:1389-1395.